PO² SRL
PO² reported total assets of €2.33m at the end of the 2025 financial year (annual accounts filed with the NBB on 15 Jun 2026).
The score of PO² shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +18 % Total assets 0 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
PO²'s annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 15 Jun 2026
- Year ended 31 Dec 2024filed on 23 Jun 2025
- Year ended 31 Dec 2023filed on 04 Jul 2024
- Year ended 31 Dec 2022filed on 26 Jul 2023
- Year ended 31 Dec 2021filed on 15 Jul 2022
PO²'s financial analysis
- Solvency45.3%sector median: 40.1%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of PO²
PO²'s publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0598.929.369
- VAT number
- BE0598929369
- Peppol
- Registered · 0208:0598929369 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 24 Feb 2015
- Registered office
- 6850 Paliseul
- Latest accounts
- 2025 · filed on 15 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
PO² (SRL) has been based in Paliseul since 2015, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 48,617 € and equity of €1.06m; its revenue is not published. Its solvency stands at 45.3%, above the median of its sector (40.1%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to PO²
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie de Neef - Duez Retail sale of pharmaceutical products Mons · balance sheet 181,026 €
- Apotheek van Geluwe Retail sale of pharmaceutical products Nieuwpoort · balance sheet €2.25m
- Geassocieerde Apotheek Mast Retail sale of pharmaceutical products Antwerp · balance sheet €2.23m
- Elpers Farma Retail sale of pharmaceutical products Dilbeek · balance sheet €2.20m
- Lenssen Sofie Retail sale of pharmaceutical products Houthalen-Helchteren · balance sheet €2.20m
- Notika Retail sale of pharmaceutical products Ninove · balance sheet €2.51m
- DR Pharma Retail sale of pharmaceutical products Bièvre · balance sheet €2.15m
- DSTM Holding Retail sale of pharmaceutical products Léglise · balance sheet €2.14m
Frequently asked questions about PO²
What is the revenue of PO²?
PO² files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of PO²?
In Belgium, the VAT number is the company number prefixed with BE: BE0598929369 for PO², if the company is VAT-registered. Its company number (CBE) is 0598.929.369.
Where is the registered office of PO²?
According to the CBE register, the registered office of PO² is in 6850 Paliseul.
What is the equity of PO²?
At the close of the 2025 financial year, the equity of PO² amounts to 1,055,820 €, a solvency of 45.3% of total assets.
Who manages PO²?
The register lists 4 active mandates at PO². Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of PO²
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →